Please provide your email address to receive an email when new articles are posted on . Kevzara is approved for polyarticular JIA in patients weighing 63 kg or greater. The drug is an IL-6 inhibitor ...
TARRYTOWN, N.Y. and CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results